Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PanGenetics UK Limited
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Arthritis that meets Classification of Psoriatic Arthritis (CASPAR) criteria
Plaque psoriasis for at least 6 months prior to study enrollment
You may not be if
Clinically significant psoriasis flare
Unstable doses of pain relief medication
Treatment with systemic corticosteroids other than prednisone ≤ 10 mg/day or equivalent
Treatment with any biologic therapy
Treatment with immunosuppressive agents or disease modifying anti-rheumatic drugs (DMARDs) other than methotrexate
Treatment with lithium, any anti-malarial, chlorambucil, cyclophosphamide or therapies for psoriasis other than low potency topical corticosteroids on intertriginous and groin areas, tar or salicylate preparations on the scalp, and emollients and moisturisers
Family history of multiple thrombotic events or a personal history of any venous or arterial thrombotic event
Clinically significant result for anti-cardiolipin, Activated protein C resistance test, Protein C, Free Protein S, Antithrombin III, Factor V Leiden, Prothrombin variant, Homocysteine, Lupus anticoagulant, Prothrombin time, Activated partial thromboplastin time, Fibrinogen, Thrombin time, Factors IX and XI
Currently smoking ≥ 10 cigarettes per day or equivalent
Active tuberculosis or other infection
Current or previous malignancies
Clinically significant abnormality on physical examination, laboratory testing, vital signs or 12-lead electrocardiogram
